Janssen Announces U.S. FDA Accelerated Approval for SIRTURO ® (bedaquiline) as Part of Combination Therapy to Treat Adolescents with Pulmonary Multidrug-Resistant Tuberculosis

Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news